// App-Quantinova.ai

231 : Serum interferon score predicts clinical outcome at 12 months in diffuse cutaneous systemic sclerosis as measured by Global Ranked Composite Score (GRCS) and Composite Response Index in SSc (CRISS)

Researchers

Presenter

  • Antonio Carriero

Principal Investigators

  • Giuseppina Abignano

  • Mitchelle Hutchinson

  • Karri Ballard

  • Sookhoe Eng

  • Paul Emery

  • Maya H Buch

  • Francesco Del Galdo

Medical Centers

  • Rheumatology Clinic, Department of Medical and Surgical Sciences, University of Foggia, Foggia, ITALY

  • Rheumatology Institute of Lucania (IRel) - Rheumatology Department of Lucania, San Carlo Hospital of Potenza and Madonna delle Grazie Hospital of Matera, Potenza

  • Myriad RBM, Myriad RBM, Austin, TX

  • NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, LEEDS, UK

Locations

  • United Kingdom

  • Italy

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Scleroderma

Biomarkers

  • C-C Motif Chemokine Ligand 2

  • C-X-C motif chemokine 10

  • C-X-C motif chemokine ligand 9

  • Chemokine (C-C motif) ligand 19

Drug/Treatment

  • Interferon

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved